AANA Announces New Corporate Partner

  • Jan 21, 2015

For Immediate Release:  January 21, 2015    
For More Information Contact: marketing@aana.com
 
Park Ridge, Illinois—Covidien is partnering with anesthesia professionals to advance patient safety through the Corporate Partners Program formed by the American Association of Nurse Anesthetists (AANA). The program seeks to combine the collective strengths of its 48,000-member association with companies that deliver the products and services used by Certified Registered Nurse Anesthetists (CRNAs) to provide ever-safer patient care.
 
Two other corporate partners have already joined the program. PharMEDium and Merck are the companies that have signed on with the AANA. “Collaboration fuels progress,” said AANA Chief Executive Officer, Wanda Wilson, CRNA, PhD. “Partnering with the AANA and the AANA Foundation provides companies with close access to CRNAs, anesthesia specialists who are the hands-on providers of more than 34 million anesthetics each year in the United States. The AANA values the additional strides in anesthesia research and practice we are able to take because of these partnerships, which help CRNAs lead the way in anesthesia safety.”
 
Covidien is a global healthcare leader that understands the challenges faced by providers and their patients and works to address them with innovative medical technology solutions and patient care products. Inspired by patients and caregivers, Covidien’s team of dedicated professionals is privileged to help save and improve lives around the world. With more than 39,000 employees, Covidien operates in 150-plus countries. Covidien monitoring products used by anesthesia providers include Nellcor™ Pulse Oximetry, Microstream™ Capnography, BIS™ Brain Function Monitoring, and INVOS™ Cerebral Oximetry. Additionally, Covidien produces Mallinckrodt™ and Shiley™ airways products and is the sole acute care distributor for the McGRATH® MAC Enhanced Direct Laryngoscope.
 
Covidien is the sole acute care distributor for the McGRATH® MAC video laryngoscope in the U.S., UK, Japan, Latin America, Australia, New Zealand, Ireland and Canada.
 
The McGRATH® MAC video laryngoscope complies with EN 60601-1 and EN 60601-1-2 safety standards. The CE mark indicates that it meets the requirements of European Council Directive 93/42/EEC concerning medical devices. The device is regulated in the USA under FDA Regulation Number 868.5540 and device listed under the name “McGRATH MAC.”
 
“McGRATH” and "Aircraft" are registered trademarks of Aircraft Medical Limited. "Camerastick" and "X blade" are trademarks of Aircraft Medical Limited.
 
About the American Association of Nurse Anesthetists
 

Current Press Releases